It always comes back to knowing your definition of success–and for complex workflows, you also need to think about what ...

The rising prevalence of cancer worldwide, increasing adoption of minimally invasive diagnostic tests, and advances in ...

The integrated platform decreases manual effort by 30–50%, reduces total expenses by up to 25%, and speeds up turnaround ...

This infographic will explore how NGS has contributed to advances in personalized cancer treatment, microbiome research and ...

SOPHiA Genetics & Jessa Ziekenhuis partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium: Boston Monday, September 8, 2025, 16:00 H ...

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...

Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA ...

Traditional tissue biopsy is invasive, time-consuming, and often impractical in advanced or metastatic disease. Liquid biopsy—non-invasive sampling of circulating tumor DNA (ctDNA), circulating tumor ...

The global DNA methylation market is projected to expand from USD 1.9 billion in 2025 to USD 7.7 billion by 2035, registering ...